The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Mar 2011 12:17

RNS Number : 5710D
Surgical Innovations Group PLC
24 March 2011
 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Surgical Innovations Group

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

 X

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 

 

Williams de Broë Ltd

4. Full name of shareholder(s) (if different from 3.):

 

Pershing Nominees Ltd (Nominee company used by Williams de Broë)

5. Date of the transaction and date on which the threshold is crossed or reached:

 

 

18 March 2011

6. Date on which issuer notified:

 

 

22 March 2011

7. Threshold(s) that is/are crossed or reached:

 

 

Below 5%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

20,129,642

 20,129,642

18,829,642

18,829,642

4.935%

 GB0004016704

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 18,829,642

4.935%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

 

Caroline Daniels - Compliance Officer

15. Contact telephone number:

 

 

020 7645 1889

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUSAURANAOUAR
Date   Source Headline
18th Oct 20137:00 amRNSCFO to present at London Investor Show
17th Oct 20137:00 amRNSInternational Clinical Advisory Board Appointment
4th Oct 20137:00 amRNSAppointment to the Clinical Advisory Board
10th Sep 20137:00 amRNSInterim Results
16th Aug 20137:00 amRNSTrading update
19th Jun 20134:06 pmRNSResult of AGM
19th Jun 20132:00 pmRNSAGM Statement
10th Jun 20137:00 amRNSPilot hip arthroscopy test
3rd Jun 20137:00 amRNSAppointment to the Clinical Advisory Board
29th May 20137:00 amRNSNew US dealer
22nd May 20137:00 amRNSDevelopment agreement for Industrial application
8th May 20137:00 amRNSSnr Appointment of President US Sales & Operations
17th Apr 20137:00 amRNSAppointment to the Clinical Advisory Board
9th Apr 20137:00 amRNSPreliminary Results
18th Mar 20137:00 amRNSChange of Adviser
11th Mar 20137:00 amRNSUS appointment to ICAB
19th Feb 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSPretzelFlex 3mm FDA approval
22nd Jan 20137:00 amRNSSecond order of 5mm PretzelFlex® shipped
17th Jan 20137:00 amRNSSI to benefit from £5.05m RGF Grant
10th Jan 20137:00 amRNSDirectors shareholding
18th Dec 20129:24 amRNSDirectors' dealings and issue of equity
18th Dec 20127:00 amRNSAppointments to the Clinical Advisory Board
29th Oct 20127:00 amRNSFirst PretzelFlex® orders shipped to CareFusion
11th Oct 20127:00 amRNSSuccessful exhibition at ISHA in the US
18th Sep 20127:00 amRNSHalf Yearly Report
4th Sep 20127:00 amRNSNotice of Results
30th Aug 20122:14 pmRNSHolding(s) in Company
26th Jun 20127:00 amRNSGrant of options
19th Jun 20123:33 pmRNSResult of AGM
19th Jun 20127:00 amRNSAGM Statement
18th Jun 20127:00 amRNSOEM distribution agreement with CareFusion
31st May 20127:00 amRNSUK distribution agreement
25th May 201211:58 amRNSDirectorate Change
22nd May 20127:00 amRNSPublication of Annual Report and Notice of AGM
1st May 20127:00 amRNSInvestor site visit
24th Apr 20127:00 amRNSFinal Results
20th Apr 20127:00 amRNSNotice of Results
15th Mar 20127:00 amRNSFDA 510(k) approval for reusable PretzelFlexT
23rd Feb 20124:54 pmRNSHolding(s) in Company
17th Feb 20124:36 pmRNSDirector/PDMR Shareholding
14th Feb 20125:49 pmRNSIssue of Equity
1st Feb 20127:00 amRNSRe: US contract and FDA approval
23rd Jan 20127:01 amRNSTrading Statement
2nd Dec 20117:00 amRNSInvestor Site Visit
3rd Nov 20117:00 amRNSIssue of Equity
1st Nov 20117:00 amRNSConfirmation of successful RGF bid
21st Sep 20114:49 pmRNSIssue of Equity
14th Sep 20117:00 amRNSHalf Yearly Report
1st Sep 20115:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.